V. Santagada et al. / Bioorg. Med. Chem. Lett. 14 (2004) 4491–4493
4493
(
EDC activation), while were comparable (compd 9) or
higher (compd 1–3) respect the conventional heating
Table 1). Even in the solvent free method the presence
Compd. (NY) 1999, 35, 630; (h) Ooi, N. S.; Wilson, D. A. J.
Chem. Soc., Perkin Trans. 2 1980, 1792; (i) Anderseen, K.
E.; Lundt, B. F.; Joergensen, A. S.; Braestrup, C. Eur. J.
Med. Chem. 1996, 31, 417; (j) Gangloff, A. R.; Litvack, J.;
Shelton, J. E. J.; Sperandio, D.; Wang, V. R.; Rice, K. D.
Tetrahedron Lett. 2001, 42, 1441; (k) Hebert, N.; Hannah,
A. L.; Sutton, S. C. Tetrahedron Lett. 1999, 40, 8547; (l)
Oussaid, B.; Moeini, L.; Martin, B.; Villemin, D.; Garri-
gues, B. Synth. Commun. 1995, 25, 1451.
(
of a withdrawing group provided higher reaction yields.
In contrast to that observed in both the solution meth-
ods, the activation by DCC/HOBt represents the opti-
mal condition. No further yield increasing was
evidenced when the irradiation time was prolonged for
over 4min; this is related to the decomposition of the
starting materials. Finally, neat reaction was not suc-
cessful (we did not noticed the presence of the final com-
pound even if heating was prolonged for over 30min).
4. (a) Santagada, V.; Perissutti, E.; Fiorino, F.; Vivenzio, B.;
Caliendo, G. Tetrahedron Lett. 2001, 42, 2397; (b) Santa-
gada, V.; Fiorino, F.; Perissutti, E.; Severino, B.; De
Filippis, V.; Vivenzio, B.; Caliendo, G. Tetrahedron Lett.
2001, 42, 5171; (c) Caliendo, G.; Fiorino, F.; Perissutti, E.;
Severino, B.; Gessi, S.; Cattabriga, E.; Borea, P. A.;
Santagada, V. Eur. J. Med. Chem. 2001, 36(11–12), 873;
(d) Santagada, V.; Perissutti, E.; Caliendo, G. Curr. Med.
Chem. 2002, 9, 1251.
. (a) Loupy, A.; Petit, A.; Hamelin, J.; Texier-Boullet, F.;
Jacquault, P.; Mathe, D. Synthesis 1998, 1213–1234; (b)
Galema, S. A. Chem. Soc. Rev. 1997, 26, 233–238; (c)
Caddick, S. Tetrahedron 1995, 51, 10403; (d) Larhed, M.;
Hallberg, A. Drug Discov. Today 2001, 6, 406.
. General procedure of 1,2,4-oxadiazole derivatives in solu-
tion: Commercially available (Aldrich) p-toluene amidoxi-
me (1mmol) and 1equiv of carboxylic acid were dissolved
in 10mL of the solvent (diglyme or DMF) in the presence of
the coupling reagents (1equiv). An opportune quantity of
base (N-ethyldiisopropylamine) was added when TBTU/
HOBt was used. The reaction mixture was kept at room
temperature, under nitrogen atmosphere, overnight.
Then the vessel containing reaction mixture was transferred
in the microwave oven and was heated at 100°C by
application of microwave energy for 30min. The desired
parameters (microwave power, temperature and time) were
set as reported in Table 1. The reaction was monitored by
TLC. After irradiation, the solvent was removed and the
In conclusion, we have shown that the application of
microwave irradiation in to the solution method in pres-
ence of a peptide coupling reagent improves the yields of
1
,2,4-oxadiazole derivatives and significantly reduces
5
6
reaction times. Furthermore, when the cyclization was
performed under solvent free condition, reaction times
were strongly reduced although yields were not so satis-
factory.
Abbreviations and symbols. We have followed the recom-
mendations of the IUPAC-IUB Joint Commission on
Biochemical Nomenclature (Eur. J. Biochem. 1984,
1
TBTU,
38, 9). In addition the following abbreviations are used:
0 0
O-(1H-benzotriazol-1-yl)-N,N,N ,N -tetrame-
thyluronium tetrafluoroborate; HOBt, 1,2,3-benzotrial-
ole-1-hydroxide; DCC, dicyclohexyl-carbodiimide;
EDC, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide
0
hydrochloride; CDI, 1,1 -carbonyldiimidazole.
References and notes
crude residue was purified by silica gel chromatography.
1,2,4-Oxadiazole derivatives were characterized by
NMR and MS and the data were consistent with the
considered structures. NMR spectra were recorded on a
Bruker WM 500 spectrometer using tetramethylsilane as an
internal standard. For the H-substituted derivatives (1–5):
1
H
1
. (a) Vu, C. B.; Corpuz, E. G.; Merry, T. J.; Pradeepan, S. G.;
Bartlett, C.; Bohacek, R. S.; Botfield, M. C.; Lynch, B. A.;
MacNeil, I. A.; Ram, M. K.; van Schravendijk, M. R.;
Violette, S.; Sawyer, T. K. J. Med. Chem. 1999, 42, 4088;
(b) Street, L. J.; Baker, R.; Castro, J. L.; Chambers, M. S.;
Guiblin, A. R.; Hobbs, S. C.; Matassa, V. G.; Reeve, A. J.;
Beer, M. S.; Middlemiss, D. N. J. Med. Chem. 1993, 36,
1529; (c) Clithirow, J. W.; Beswick, P.; Irving, W. J.;
Scopes, D. I. C.; Barnes, J. C.; Clapham, J.; Brown, J. D.;
Evans, D. J.; Hayes, A. G. Bioorg. Med. Chem. Lett. 1996,
6, 833; (d) Swain, C. J.; Baker, R. A.; Kneen, C.; Mosely, J.;
mp 98–100°C, ESI: calcd for C15
H
N
O 237.26, found
): d 8.21 (d, 2H), d 8.08 (d,
2H), d 7.64 (dd, 1H), d 7.58 (d, 2H), d 7.37 (d, 2H), d 2.42 (s,
3H). NO
-substituted derivatives (6,7): mp 167–169°C,
ESI: calcd for C15
12
2
+
1
237.27 (MH ); H NMR (CDCl
3
2
+
H
N
O
282.27, found 287.26 (MH );
): d 8.41 (d, 4H), d 8.07 (d, 2H), d 7.34 (d,
2H), d 2.44 (s, 3H); OEt-substituted derivatives (8,9): mp
119–121°C, ESI: calcd for C17 281.31, found
3
281.32 (MH ); H NMR (CDCl ): d 8.13 (d, 2H), d 8.05
11
3
3
1
H NMR (CDCl
3
Saunders, J.; Seward, E. M.; Stevenson, G.; Beer, M.;
Stanton, J.; Watling, K. J. Med. Chem. 1991, 34, 140.
. (a) Orlek, B. S.; Balaney, F. E.; Braun, F.; Clark, M. S. G.;
Hadley, M. S.; Hatcher, J.; Riley, G. J.; Rosenberg, H. E.;
Wadsworth, H. J.; Wyman, P. J. Med. Chem. 1991, 34,
H N O
16 2 2
+
1
2
(d, 2H), d 7.31 (d, 2H), d 7.02 (d, 2H), d 4.11 (q, 2H), d 2.42
(s, 3H), d 1.46 (t, 3H).
2
726; (b) Watjen, F.; Baker, R.; Engelstoff, M.; Herbert, R.;
7. Synthesis of 1,2,4-oxadiazole derivatives under solvent free
conditions: p-Toluene amidoxime (1mmol), benzoic substi-
tuted acid (1equiv) and coupling reagents (1equiv) were
mixed with the neutral alumina in a 4:1 ratio. The mixture
was shacked for 5min. To have a complete mixing in the
powder, dichloromethane was added in small quantity to
solubilize the reagents and then the solvent was evaporated.
The reaction mixture was then irradiated by microwave for
4min. The desired parameters (microwave power, temper-
ature and time) were set as reported in Table 1. After
irradiation the solid was extracted in dichloromethane
MacLeod, A.; Knight, A.; Merchant, K.; Moseley, J.;
Saunders, J.; Swain, J.; Wong, E.; Springer, J. P. J. Med.
Chem. 1989, 32, 2282; (c) Ankersen, M.; Peschke, B.;
Hansen, B. S.; Hansen, T. K. Biorg. Med. Chem. Lett. 1997,
7
, 1293.
. (a) Kaboudin, B.; Navaee, K. Heterocycles 2003, 60, 2287;
b) Liang, G. B.; Feng, D. D. Tetrahedron Lett. 1996, 37,
3
(
6627; (c) Rice, K. D.; Nuss, J. M. Bioorg. Med. Chem. Lett.
2001, 11, 753; (d) Clapp, L. B. Adv. Heterocycl. Chem. 1976,
20, 65; (e) Korbonits, D.; Horvath, K. Heterocycles 1994,
37, 2051; (f) Chiou, S.; Shine, H. J. J. Heterocycl. Chem.
1989, 26, 125; (g) Kayukova, L. A.; Praliev, K. D.;
1
and purified by silica gel chromatography. H NMR
spectra and MS data were consistent witht he considered
structures.
Zhumadildaeva, I. S.; Klepikova, S. G. Chem. Heterocycl.